May 12, 2020
The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028
May 11, 2020
Hikma launches employee matching donation campaign to support local US food banks and pantries
May 04, 2020
Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases
May 04, 2020
Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain diseases with up to 94% accuracy
Mar 04, 2020
Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates
Feb 27, 2020
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris(TM) Seasonal Allergic Rhinitis Nasal Spray in the US
Jan 09, 2020
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat(TM) technology
Jul 23, 2019
Hikma and Civica Rx sign long-term agreement to reduce generic drug shortages in the US
May 03, 2019
The Pharmaceuticals Market in Kuwait to 2022 - Pfizer had the Majority Share in 2017
May 02, 2019
Hikma Sponsors MIT Grand Hack to Support Global Healthcare Innovation
Dec 04, 2018
Global Opioids Drug Market Forecast 2019-2027
Jul 18, 2018
Hikma Acts to Ease Critical Shortage of Pain Medications Needed by US Hospitals and Their Patients
Apr 23, 2018
Generic Injectables Market to Generate a Revenue of US$ 150 Bn by 2025, Says TMR
Aug 17, 2017
Hikma Announces Expanded Licensing Agreement with Takeda for New Products in the Middle East and North Africa